EA
CVS icon

Euclid Advisors’s CVS Health CVS Stock Holding History

Euclid Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-133,377
Closed -$12.8M – 124
2016
Q2 		$12.8M Sell
133,377
-28,750
-18% -$2.87M 0.56% 46
2016
Q1 		$16.8M Sell
162,127
-169,145
-51% -$16.4M 0.64% 39
2015
Q4 		$32.4M Sell
331,272
-13,405
-4% -$1.31M 0.99% 14
2015
Q3 		$33.3M Sell
344,677
-109,020
-24% -$11.5M 1.51% 16
2015
Q2 		$47.6M Buy
453,697
+310,058
+216% +$31.7M 0.94% 17
2015
Q1 		$14.8M Sell
143,639
-772,468
-84% -$78.2M 0.27% 80
2014
Q4 		$88.2M Buy
916,107
+27,507
+3% +$2.42M 0.82% 25
2014
Q3 		$70.7M Buy
888,600
+98,370
+12% +$7.75M 0.51% 38
2014
Q2 		$59.6M Buy
+790,230
New +$59.7M 0.42% 44
2014
Q1 		– Sell
-646,290
Closed -$46.3M – 416
2013
Q4 		$46.3M Buy
+646,290
New +$41.5M 0.38% 55
2013
Q3 		– Sell
-511,240
Closed -$29.2M – 487
2013
Q2 		$29.2M Buy
+511,240
New +$29.6M 0.37% 59

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Euclid Advisors's CVS Position: Q3 2016 in Review

Euclid Advisors sold out of CVS Health (CVS) in Q3 2016, closing a stake of 133,377 shares — an estimated $12.8M sold.

Euclid Advisors first reported a position in CVS in Q2 2013 and held it in 11 quarters. The position peaked at $88.2M in Q4 2014. 1,564 funds tracked by Wall St. Rank hold CVS as of Q3 2016.

  • Euclid Advisors reported no remaining CVS Health position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 133,377 CVS Health shares in Q3 2016, an estimated $12.8M.
  • Euclid Advisors first reported a position in CVS Health in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's CVS Health position peaked at $88.2M in Q4 2014.
  • 1,564 funds tracked by Wall St. Rank held CVS Health as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.